Life Sciences

Researchers have identified the molecular mechanism by which cells detect potassium leakage and trigger inflammation—a process linked to heart disease, diabetes, and neurodegeneration. The discovery could enable drug developers to design more targeted anti-inflammatory therapies by directly modulating this newly understood sensor.EN

Researchers have developed RETrace2, a method that tracks how cells divide and differentiate by reading genetic mutations with unprecedented accuracy. The advance could accelerate drug development for regenerative medicine and cancer, while offering better tools to understand why organs fail or tumors form.EN

Scientists discovered that a long non-coding RNA called ACHLYS acts as a master switch controlling how plant genes are spliced—fundamentally altering root architecture. The finding could unlock new ways to engineer crops for better stress tolerance and yield, with implications for agricultural productivity as climate pressures mount.EN

Researchers have published a comprehensive taxonomy of breast cancer subtypes, risk factors, and predictive biomarkers to guide clinical decision-making. The work consolidates fragmented knowledge into a single reference, potentially accelerating treatment selection and improving outcomes for diagnostics companies and healthcare providers.EN

Researchers have identified 75 genes that control bone density by mapping how genetic variants in noncoding DNA regions affect bone cell behavior. The discovery could accelerate development of osteoporosis treatments beyond current options, potentially reducing fracture risk in millions of aging patients and lowering healthcare costs associated with bone disease.EN

A new study calls for EU-wide standardization of genetic counselor training, licensing, and legal recognition to address inconsistent access across member states. The fragmentation creates equity gaps and mobility barriers as genomic medicine becomes routine in healthcare, prompting policymakers to align regulations and professional credentials.EN

Researchers tested whether talking to yourself in the third person could ease physical pain—a strategy that showed promise in earlier studies. The large experiment found no meaningful benefit, suggesting pain management approaches may need to look beyond this psychological technique.EN

Researchers tracked individual immune cells and found that the body's inflammatory response varies depending on what triggered it—challenging decades of assumptions that the reaction was identical each time. The finding could reshape how companies develop drugs targeting inflammation-related diseases like arthritis and sepsis.EN

A rigorous clinical trial of mistletoe extract—a popular complementary therapy—found no meaningful benefit for pancreatic cancer patients' quality of life, weight, or survival markers. The finding matters because it challenges widespread use of an unproven treatment and could reshape how oncology centers allocate resources for palliative care.EN

Researchers identified a potential biomarker for predicting which hydrocephalus patients will benefit from shunt surgery—a protein called aquaporin-4 that rises sharply after the procedure. The finding could help doctors identify ideal surgical candidates and track treatment success, potentially reducing unnecessary operations for this common neurological condition affecting mobility and cognition in elderly patients.EN

Researchers discovered that the brain fundamentally alters how soft skin feels depending on whether you're touching yourself or being touched by someone else—and that the direction of contact matters more than the actual movement. The finding could reshape how companies design haptic feedback systems, prosthetics, and therapeutic devices that aim to replicate natural touch.EN

Researchers have identified why touching yourself feels less intense than being touched by others—a finding that could reshape how companies design virtual reality, robotics, and human-machine interfaces. The study shows the sensation depends on which body part receives touch, not the hand doing the touching, offering concrete guidance for technology that needs to feel naturally responsive to users.EN

Researchers identified a new genetic cause of dangerous low blood sugar in a newborn with Sotos syndrome, a rare overgrowth disorder. The finding could help doctors recognize and treat this life-threatening complication earlier, improving outcomes for affected infants and informing genetic screening protocols in pediatric care.EN

A 13-year study in Sweden reveals that relying solely on laboratory tests for Lyme neuroborreliosis could underestimate disease burden by up to 40%. The findings challenge EU surveillance recommendations and suggest current diagnostic protocols may be missing cases in children and other populations, with implications for public health monitoring across Europe.EN

Researchers identified abnormal patterns in immune checkpoint proteins among patients with peripheral artery disease, a condition affecting millions and driving significant healthcare costs. The findings could lead to new diagnostic tests and treatments that target the immune system's role in clogged arteries.EN

A major study of 35,640 colon cancer patients found that those with inflammatory bowel disease had comparable survival rates to others after surgery, challenging assumptions about disease complexity. The finding could reshape treatment protocols and patient counseling for the roughly 2% of colon cancer patients with IBD, potentially reducing unnecessary intensive interventions.EN

Researchers found that inflammation markers predict decline in dopamine receptors among adults over 60, with effects differing sharply between men and women. The discovery could reshape how companies develop treatments for age-related cognitive decline and inform public health strategies for managing inflammation in older populations.EN

Scientists found that a natural protein called lactoferricin dramatically improves how adenoviruses deliver genes into muscle cells—boosting infection rates by up to 30-fold while shielding the virus from antibody attacks. The discovery could unlock muscle-targeting gene therapies for muscular dystrophies and other genetic diseases that currently lack effective treatments.EN

Researchers have developed a compression method that allows complex AI models to run on cheap, battery-powered IoT devices without sacrificing accuracy. The approach could unlock deployment of advanced machine learning across manufacturing floors, farms, and remote locations where cloud connectivity is unreliable or expensive.EN

Researchers have pinpointed CD46 as the primary receptor that human adenoviruses use to infect cells, a discovery that could improve the design of adenovirus-based gene therapies and vaccines. The finding explains why current adenovirus vectors infect so many cell types, and offers a path toward more targeted treatments with fewer off-target effects.EN

Researchers discovered that elevated taurine levels—the kind found naturally in ovarian cancer patients—paradoxically protect cancer cells from cisplatin chemotherapy by activating protective cellular pathways. The finding raises questions about whether taurine supplementation could undermine treatment efficacy and suggests oncologists may need to reconsider dietary recommendations for ovarian cancer patients undergoing therapy.EN

Researchers found that a single ribosomal protein adopts entirely different 3D structures depending on which organism hosts it—a discovery that rewrites assumptions about how evolution modifies cellular machinery. The finding suggests cells can repurpose ancient proteins in radically new ways, potentially opening paths to new antibiotics targeting parasitic microbes resistant to current drugs.EN

A genetic variant linked to low-grade brain tumors doesn't work the way researchers expected, according to new findings. The discovery suggests cancer risk variants may operate through more complex biological pathways than currently understood—potentially reshaping how pharma companies approach drug development for genetic predisposition conditions.EN

Researchers compared two classes of experimental drugs for COPD, both designed to activate Nrf2—a master switch that protects lung cells from oxidative damage. The work could accelerate development of the first treatments that address COPD's underlying biology rather than just managing symptoms, potentially opening a significant new market.EN

Researchers combined genetic data with machine learning to predict which drug candidates will succeed in clinical trials, achieving a 6.4-fold improvement over standard approaches. The method could reshape how pharmaceutical companies select targets, potentially reducing costly trial failures and accelerating time-to-market for viable drugs.EN